Triphala Indian (Amalaki + Bibhitaki + Haritaki): Benefits, Dosage, Safety & Evidence

Questions fréquentes

How does Triphala work as a digestive tonic?

Triphala works through a synergistic mechanism involving its three fruits: Amalaki, Bibhitaki, and Haritaki. The active compounds, including gallic acid and tannins, provide antioxidant protection while gently stimulating peristalsis to improve bowel motility. Haritaki acts as a gentle laxative, Bibhitaki helps clear mucus from the digestive tract, and Amalaki supports tissue rejuvenation. Unlike stimulant laxatives, this combination promotes detoxification and regularity without causing dependency or irritation to the intestinal lining. (Evidence Level: B)

Is Triphala safe to take during pregnancy?

Triphala is considered unsafe during pregnancy and should be strictly avoided. The formula contains Haritaki and Bibhitaki, which possess strong purgative properties that can stimulate uterine contractions, potentially leading to miscarriage or premature labor. Additionally, the detoxification effects may be too harsh for a developing fetus. Women who are pregnant or breastfeeding should consult a healthcare provider for safer alternatives to support digestive health. (Evidence Level: D)

What is the recommended dosage for Triphala powder?

The standard adult dosage for Triphala powder is 2 to 6 grams taken once daily. It is traditionally mixed with warm water and consumed before bed to promote morning bowel movements. For those new to the herb, starting with a lower dose of 2 grams is advisable to assess tolerance and minimize potential gastrointestinal discomfort. Consistency is key for achieving gentle detoxification and digestive support. (Evidence Level: B)

Does Triphala interact with any medications?

Triphala may interact with medications due to its effects on drug metabolism and absorption. Because it can lower blood sugar levels, it may potentiate the effects of antidiabetic drugs, requiring close monitoring. The high tannin content might also interfere with the absorption of iron supplements and certain alkaloid drugs. Patients taking blood thinners or immunosuppressants should exercise caution and consult a physician before use. (Evidence Level: C)

Can Triphala help with chronic constipation?

Yes, Triphala is widely used to manage chronic constipation. Clinical evidence suggests it acts as a gentle osmotic laxative, softening stools and promoting regular bowel movements without the harsh side effects associated with stimulant laxatives. The combination of fruits helps lubricate the intestinal tract and improve peristalsis. Because it does not typically cause dependency, it is considered suitable for long-term digestive support in adults. (Evidence Level: B)

Fiche d'information compilée à partir de PubMed

Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.

Compilé à partir de 30 articles PubMed · modèle : gemma4:31b

Résumé

Triphala is a traditional Ayurvedic formulation consisting of three fruits—Amalaki, Bibhitaki, and Haritaki—known for its antioxidant and anti-diabetic properties [PMID:35168075, PMID:34149415].

Contexte

Triphala is an Ayurvedic herbal formula composed of the fruits of Terminalia chebula (Haritaki), Terminalia bellirica (Bibhitaki), and Phyllanthus emblica or Emblica officinalis (Amalaki/Indian gooseberry) [PMID:23239004, PMID:39738152].

Usages traditionnels

In Ayurveda, it is considered a 'Rasayana' used to rejuvenate debilitated organs and is primarily used to treat various gastrointestinal disorders [PMID:23239004]. It is also used for detoxification, promoting digestion, and overall wellness [PMID:39738152].

Composés actifs

Triphala contains over 150 bioactive compounds, including polyphenols such as ellagic acid, chebulinic acid, gallic acid, and corilagin [PMID:41151054, PMID:39738152]. Analysis of extracts has also shown the presence of total phenolic compounds, hydrolyzable tannins, and flavonoids [PMID:36970454].

Mécanisme d'action

Triphala exhibits potent antioxidant, free radical scavenging, and anti-inflammatory activities [PMID:23239004, PMID:32674108]. In diabetic nephropathy, it may act via the inhibition of TGF-β1 and oxidative stress [PMID:32674108].

Preuves cliniques

Preuve DDiabetic Retinopathy

Triphala churna significantly reduced plasma glucose and oxidative stress parameters in diabetic rats [PMID:35168075]

Preuve DDiabetic Neuropathy

Triphala churna mitigated diabetic neuropathy in rats, affecting parameters such as plasma glucose and motor nerve conduction velocity [PMID:34149415]

Preuve DDiabetic Nephropathy

Triphala churna ameliorated nephropathy in rats by inhibiting TGF-β1 and oxidative stress [PMID:32674108]

Preuve BDenture Candidiasis

Triphala churna demonstrated antifungal properties against Candida albicans on heat cure denture base material [PMID:28300045]

Preuve DBrass-induced Heavy Metal Toxicity

Triphala Churna (5gm daily) combined with Dadima Svarasa was used in a pilot study to manage high serum levels of copper, zinc, and lead [PMID:34690043]

Preuve DDengue Virus Infection

Triphala inhibited dengue virus (DENV) infection in Huh7 hepatoma cells and diminished IL-6 and CXCL-10 expressions [PMID:34959637]

Sécurité et effets indésirables

A study in Sprague-Dawley rats evaluating acute (5000 mg/kg) and chronic (up to 2400 mg/kg for 270 days) oral toxicity of Maha Pigut Triphala reported no abnormalities in symptoms [PMID:39765672].

Synthèse des preuves

The evidence is primarily based on animal models (rats) and in vitro studies (D), with one randomized controlled trial (B) regarding antifungal use for dentures. Review articles (C) support its broad pharmacological potential.

Sources PubMed

1.PMID: 35168075 (2022) — Triphala churna ameliorates retinopathy in diabetic rats. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
2.PMID: 34149415 (2021) — Triphala Churna-A Traditional Formulation in Ayurveda Mitigates Diabetic Neuropathy in Rats. · Frontiers in pharmacology
3.PMID: 23239004 (2012) — Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a review. · Chinese journal of integrative medicine
4.PMID: 22171288 (2011) — Antibacterial activity of some Indian Ayurvedic preparations against enteric bacterial pathogens. · Journal of advanced pharmaceutical technology & research
5.PMID: 32674108 (2020) — Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats.

Triphala Indian

Sources et citations

Calculer une dose sûre de Triphala Indian

Triphala

Triphala Digestive

Triphala Formula

Questions fréquentes

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales

Triphala Indian

Sources et citations

Calculer une dose sûre de Triphala Indian

Plantes associées

Triphala

Triphala Digestive

Triphala Formula

Questions fréquentes

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales